Review



cd80 clone l307.4  (GraphPad Software Inc)


Bioz Verified Symbol GraphPad Software Inc is a verified supplier  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 90

    Structured Review

    GraphPad Software Inc cd80 clone l307.4
    Cd80 Clone L307.4, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cd80+clone+l307%2E4/tmr+cd80+his/pm37527263-115-52-37
    Average 90 stars, based on 1 article reviews
    cd80 clone l307.4 - by Bioz Stars, 2026-09
    90/100 stars

    Images

    Related Articles

    other:

    Article Title: Intraoperative cell salvage: The impact on immune cell numbers.
    Article Snippet: A repeated measures ANOVA with Friedmans test and Dunn’s multiple comparison test was used to count and analyse multiple immune cell populations; firstly, considering all patients and then for each study group at each time point, using GraphPad Prism *Co-stimulatory/Adhesion Molecules and pDC: CD9 (clone M-L13), CD38 (clone HIT2), CD40 (clone 5C3), CD80 (clone L307.4), CD83 (clone HB15e), CD86 (clone FUN-1), CD123 (clone 9F5).



    Similar Products

    90
    Becton Dickinson mouse anti-human cd80 - pe - clone l307.4 (1 ml/105 cells)
    Mouse Anti Human Cd80 Pe Clone L307.4 (1 Ml/105 Cells), supplied by Becton Dickinson, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cd80+clone+l307%2E4/anti+cd80/pm36853720-140-174-178
    Average 90 stars, based on 1 article reviews
    mouse anti-human cd80 - pe - clone l307.4 (1 ml/105 cells) - by Bioz Stars, 2026-09
    90/100 stars
      Buy from Supplier

    90
    GraphPad Software Inc cd80 clone l307.4
    Cd80 Clone L307.4, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cd80+clone+l307%2E4/tmr+cd80+his/pm37527263-115-52-37
    Average 90 stars, based on 1 article reviews
    cd80 clone l307.4 - by Bioz Stars, 2026-09
    90/100 stars
      Buy from Supplier

    90
    Becton Dickinson anti-cd80-bv605 clone l307.4
    Anti Cd80 Bv605 Clone L307.4, supplied by Becton Dickinson, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cd80+clone+l307%2E4/anti+cd80/pmc09969480-196-28-31
    Average 90 stars, based on 1 article reviews
    anti-cd80-bv605 clone l307.4 - by Bioz Stars, 2026-09
    90/100 stars
      Buy from Supplier

    90
    Becton Dickinson human cd80 hrzn v450 (clone: l307.4)
    mRNA gene expression analyses of selected target genes, protein analyses of IL-6 and TNF-α, and analysis of surface marker expression of HLA-DR and <t>CD80</t> to investigate the effects of non-targeted and targeted PEG-LNP(Cal) in LPS-induced human Mφ. ( A – H ) Human Mφ (1×10 6 cells/well) from buffy coats (n=3) were pretreated with different doses (0.5, 10, and 100 nM) of either PEG-LNP(Cal), PEG-LNP(Cal)-IgG(h), or PEG-LNP(Cal)-αhCD163 for 24 hours following LPS challenge (μL/mL) for 4 hours. The second derivative max method was used to calculate the relative mRNA concentration of each sample. Target gene expression levels (NF-κB, TNF-α, MCP-1, IL-6, IL-10, and CD163) were normalized to the stable housekeeping gene GAPDH expression level, and the resulting mRNA ratios were normalized to untreated control Mφ and given the value 1 (dotted horizontal line). Two-way ANOVA along with Tukey’s multiple comparisons test was performed on all targets to investigate the difference between LNP types per dose and the specific dose-dependent response per LNP type. * P ≤0.05, ** P ≤0.01, *** P ≤0.001, and **** P ≤0.0001. Asterisks over the horizontal line indicate dose-dependent significance. ( A ) # 10 nM PEG-LNP(Cal) vs 10 nM PEG-LNP(Cal)-αhCD163, * and **PEG-LNP(Cal)-IgG(h) vs PEG-LNP(Cal)-αhCD163. ( B ) ## PEG-LNP(Cal) vs PEG-LNP(Cal)-αhCD163. ( C ) **The horizontal line above shows dose-dependent significance for non-targeted and targeted PEG-LNP(Cal). ( D ) *The horizontal line above illustrates significant dose-dependent response for PEG-LNP(Cal) and PEG-LNP(Cal)-IgG(h). *For both 0.5 and 10 nM PEG-LNP(Cal)-IgG(h) vs 0.5 and 10 nM PEG-LNP(Cal)-αhCD163. ( E ) # 0.5 nM PEG-LNP(Cal) vs 0.5 nM PEG-LNP(Cal)-αhCD163, *0.5 and 100 nM PEG-LNP(Cal)-IgG(h) vs 0.5 and 100 nM PEG-LNP(Cal)-αhCD163. ( G , H ) Cell culture supernatant was collected from Mφ (n=3). Protein concentration of ( G ) IL-6 *(outlier removed from IL-6 ELISA) and ( H ) TNF-α protein level (pg/mL) was measured using a commercial human IL-6 and TNF-α kit. Dotted horizontal line indicates the protein level detected in control Mφ. Two-way ANOVA with Tukey’s multiple comparisons test was performed. ***Statistically significant difference for all 100 nM LNP types. **For all 10 nM LNP types. @@ For 0.5 nM PEG-LNP(Cal) and 0.5 nM PEG-LNP(Cal)-IgG(h). # 0.5 nM PEG-LNP(Cal) vs 0.5 nM PEG-LNP(Cal)-αhCD163. *0.5 nM PEG-LNP(Cal)-IgG(h) vs 0.5 nM PEG-LNP(Cal)-αhCD163. ( I , J ) MFI of surface markers HLA-DR and CD80 on DID + LPS-induced Mφ pretreated with 10 and 100 nM PEG-LNP(Cal)-αhCD163. Overall MFI of surface markers on live LPS-induced Mφ population; mean MFI HLA-DR: 1978 and mean MFI CD80: 446. Abbreviations: Mφ, macrophages; LNPs, lipid nanoparticles; PEG, polyethylene glycol; PEG-LNP(Cal), calcitriol PEGylated lipid nanoparticles; LPS, lipopolysaccharide; MFI, median fluorescence intensity; TNF-α, tumor necrosis factor-alpha; MCP-1, monocyte chemoattractant protein; NF, nuclear factor; IL, interleukin.
    Human Cd80 Hrzn V450 (Clone: L307.4), supplied by Becton Dickinson, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cd80+clone+l307%2E4/anti+cd3/pmc06488164-89-11-20
    Average 90 stars, based on 1 article reviews
    human cd80 hrzn v450 (clone: l307.4) - by Bioz Stars, 2026-09
    90/100 stars
      Buy from Supplier

    90
    Becton Dickinson apc-r700 anti-human cd80 (1:200, clone l307.4)
    mRNA gene expression analyses of selected target genes, protein analyses of IL-6 and TNF-α, and analysis of surface marker expression of HLA-DR and <t>CD80</t> to investigate the effects of non-targeted and targeted PEG-LNP(Cal) in LPS-induced human Mφ. ( A – H ) Human Mφ (1×10 6 cells/well) from buffy coats (n=3) were pretreated with different doses (0.5, 10, and 100 nM) of either PEG-LNP(Cal), PEG-LNP(Cal)-IgG(h), or PEG-LNP(Cal)-αhCD163 for 24 hours following LPS challenge (μL/mL) for 4 hours. The second derivative max method was used to calculate the relative mRNA concentration of each sample. Target gene expression levels (NF-κB, TNF-α, MCP-1, IL-6, IL-10, and CD163) were normalized to the stable housekeeping gene GAPDH expression level, and the resulting mRNA ratios were normalized to untreated control Mφ and given the value 1 (dotted horizontal line). Two-way ANOVA along with Tukey’s multiple comparisons test was performed on all targets to investigate the difference between LNP types per dose and the specific dose-dependent response per LNP type. * P ≤0.05, ** P ≤0.01, *** P ≤0.001, and **** P ≤0.0001. Asterisks over the horizontal line indicate dose-dependent significance. ( A ) # 10 nM PEG-LNP(Cal) vs 10 nM PEG-LNP(Cal)-αhCD163, * and **PEG-LNP(Cal)-IgG(h) vs PEG-LNP(Cal)-αhCD163. ( B ) ## PEG-LNP(Cal) vs PEG-LNP(Cal)-αhCD163. ( C ) **The horizontal line above shows dose-dependent significance for non-targeted and targeted PEG-LNP(Cal). ( D ) *The horizontal line above illustrates significant dose-dependent response for PEG-LNP(Cal) and PEG-LNP(Cal)-IgG(h). *For both 0.5 and 10 nM PEG-LNP(Cal)-IgG(h) vs 0.5 and 10 nM PEG-LNP(Cal)-αhCD163. ( E ) # 0.5 nM PEG-LNP(Cal) vs 0.5 nM PEG-LNP(Cal)-αhCD163, *0.5 and 100 nM PEG-LNP(Cal)-IgG(h) vs 0.5 and 100 nM PEG-LNP(Cal)-αhCD163. ( G , H ) Cell culture supernatant was collected from Mφ (n=3). Protein concentration of ( G ) IL-6 *(outlier removed from IL-6 ELISA) and ( H ) TNF-α protein level (pg/mL) was measured using a commercial human IL-6 and TNF-α kit. Dotted horizontal line indicates the protein level detected in control Mφ. Two-way ANOVA with Tukey’s multiple comparisons test was performed. ***Statistically significant difference for all 100 nM LNP types. **For all 10 nM LNP types. @@ For 0.5 nM PEG-LNP(Cal) and 0.5 nM PEG-LNP(Cal)-IgG(h). # 0.5 nM PEG-LNP(Cal) vs 0.5 nM PEG-LNP(Cal)-αhCD163. *0.5 nM PEG-LNP(Cal)-IgG(h) vs 0.5 nM PEG-LNP(Cal)-αhCD163. ( I , J ) MFI of surface markers HLA-DR and CD80 on DID + LPS-induced Mφ pretreated with 10 and 100 nM PEG-LNP(Cal)-αhCD163. Overall MFI of surface markers on live LPS-induced Mφ population; mean MFI HLA-DR: 1978 and mean MFI CD80: 446. Abbreviations: Mφ, macrophages; LNPs, lipid nanoparticles; PEG, polyethylene glycol; PEG-LNP(Cal), calcitriol PEGylated lipid nanoparticles; LPS, lipopolysaccharide; MFI, median fluorescence intensity; TNF-α, tumor necrosis factor-alpha; MCP-1, monocyte chemoattractant protein; NF, nuclear factor; IL, interleukin.
    Apc R700 Anti Human Cd80 (1:200, Clone L307.4), supplied by Becton Dickinson, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cd80+clone+l307%2E4/streptavidin+bv711/pmc08662539-152-0-22
    Average 90 stars, based on 1 article reviews
    apc-r700 anti-human cd80 (1:200, clone l307.4) - by Bioz Stars, 2026-09
    90/100 stars
      Buy from Supplier

    90
    Becton Dickinson human cd80–pe, clone l307.4, ref 340294 antibody
    mRNA gene expression analyses of selected target genes, protein analyses of IL-6 and TNF-α, and analysis of surface marker expression of HLA-DR and <t>CD80</t> to investigate the effects of non-targeted and targeted PEG-LNP(Cal) in LPS-induced human Mφ. ( A – H ) Human Mφ (1×10 6 cells/well) from buffy coats (n=3) were pretreated with different doses (0.5, 10, and 100 nM) of either PEG-LNP(Cal), PEG-LNP(Cal)-IgG(h), or PEG-LNP(Cal)-αhCD163 for 24 hours following LPS challenge (μL/mL) for 4 hours. The second derivative max method was used to calculate the relative mRNA concentration of each sample. Target gene expression levels (NF-κB, TNF-α, MCP-1, IL-6, IL-10, and CD163) were normalized to the stable housekeeping gene GAPDH expression level, and the resulting mRNA ratios were normalized to untreated control Mφ and given the value 1 (dotted horizontal line). Two-way ANOVA along with Tukey’s multiple comparisons test was performed on all targets to investigate the difference between LNP types per dose and the specific dose-dependent response per LNP type. * P ≤0.05, ** P ≤0.01, *** P ≤0.001, and **** P ≤0.0001. Asterisks over the horizontal line indicate dose-dependent significance. ( A ) # 10 nM PEG-LNP(Cal) vs 10 nM PEG-LNP(Cal)-αhCD163, * and **PEG-LNP(Cal)-IgG(h) vs PEG-LNP(Cal)-αhCD163. ( B ) ## PEG-LNP(Cal) vs PEG-LNP(Cal)-αhCD163. ( C ) **The horizontal line above shows dose-dependent significance for non-targeted and targeted PEG-LNP(Cal). ( D ) *The horizontal line above illustrates significant dose-dependent response for PEG-LNP(Cal) and PEG-LNP(Cal)-IgG(h). *For both 0.5 and 10 nM PEG-LNP(Cal)-IgG(h) vs 0.5 and 10 nM PEG-LNP(Cal)-αhCD163. ( E ) # 0.5 nM PEG-LNP(Cal) vs 0.5 nM PEG-LNP(Cal)-αhCD163, *0.5 and 100 nM PEG-LNP(Cal)-IgG(h) vs 0.5 and 100 nM PEG-LNP(Cal)-αhCD163. ( G , H ) Cell culture supernatant was collected from Mφ (n=3). Protein concentration of ( G ) IL-6 *(outlier removed from IL-6 ELISA) and ( H ) TNF-α protein level (pg/mL) was measured using a commercial human IL-6 and TNF-α kit. Dotted horizontal line indicates the protein level detected in control Mφ. Two-way ANOVA with Tukey’s multiple comparisons test was performed. ***Statistically significant difference for all 100 nM LNP types. **For all 10 nM LNP types. @@ For 0.5 nM PEG-LNP(Cal) and 0.5 nM PEG-LNP(Cal)-IgG(h). # 0.5 nM PEG-LNP(Cal) vs 0.5 nM PEG-LNP(Cal)-αhCD163. *0.5 nM PEG-LNP(Cal)-IgG(h) vs 0.5 nM PEG-LNP(Cal)-αhCD163. ( I , J ) MFI of surface markers HLA-DR and CD80 on DID + LPS-induced Mφ pretreated with 10 and 100 nM PEG-LNP(Cal)-αhCD163. Overall MFI of surface markers on live LPS-induced Mφ population; mean MFI HLA-DR: 1978 and mean MFI CD80: 446. Abbreviations: Mφ, macrophages; LNPs, lipid nanoparticles; PEG, polyethylene glycol; PEG-LNP(Cal), calcitriol PEGylated lipid nanoparticles; LPS, lipopolysaccharide; MFI, median fluorescence intensity; TNF-α, tumor necrosis factor-alpha; MCP-1, monocyte chemoattractant protein; NF, nuclear factor; IL, interleukin.
    Human Cd80–Pe, Clone L307.4, Ref 340294 Antibody, supplied by Becton Dickinson, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cd80+clone+l307%2E4/anti+cd80/pmc08490940-258-6-9
    Average 90 stars, based on 1 article reviews
    human cd80–pe, clone l307.4, ref 340294 antibody - by Bioz Stars, 2026-09
    90/100 stars
      Buy from Supplier

    90
    Becton Dickinson cd80-apc/h7 (clone l307.4)
    mRNA gene expression analyses of selected target genes, protein analyses of IL-6 and TNF-α, and analysis of surface marker expression of HLA-DR and <t>CD80</t> to investigate the effects of non-targeted and targeted PEG-LNP(Cal) in LPS-induced human Mφ. ( A – H ) Human Mφ (1×10 6 cells/well) from buffy coats (n=3) were pretreated with different doses (0.5, 10, and 100 nM) of either PEG-LNP(Cal), PEG-LNP(Cal)-IgG(h), or PEG-LNP(Cal)-αhCD163 for 24 hours following LPS challenge (μL/mL) for 4 hours. The second derivative max method was used to calculate the relative mRNA concentration of each sample. Target gene expression levels (NF-κB, TNF-α, MCP-1, IL-6, IL-10, and CD163) were normalized to the stable housekeeping gene GAPDH expression level, and the resulting mRNA ratios were normalized to untreated control Mφ and given the value 1 (dotted horizontal line). Two-way ANOVA along with Tukey’s multiple comparisons test was performed on all targets to investigate the difference between LNP types per dose and the specific dose-dependent response per LNP type. * P ≤0.05, ** P ≤0.01, *** P ≤0.001, and **** P ≤0.0001. Asterisks over the horizontal line indicate dose-dependent significance. ( A ) # 10 nM PEG-LNP(Cal) vs 10 nM PEG-LNP(Cal)-αhCD163, * and **PEG-LNP(Cal)-IgG(h) vs PEG-LNP(Cal)-αhCD163. ( B ) ## PEG-LNP(Cal) vs PEG-LNP(Cal)-αhCD163. ( C ) **The horizontal line above shows dose-dependent significance for non-targeted and targeted PEG-LNP(Cal). ( D ) *The horizontal line above illustrates significant dose-dependent response for PEG-LNP(Cal) and PEG-LNP(Cal)-IgG(h). *For both 0.5 and 10 nM PEG-LNP(Cal)-IgG(h) vs 0.5 and 10 nM PEG-LNP(Cal)-αhCD163. ( E ) # 0.5 nM PEG-LNP(Cal) vs 0.5 nM PEG-LNP(Cal)-αhCD163, *0.5 and 100 nM PEG-LNP(Cal)-IgG(h) vs 0.5 and 100 nM PEG-LNP(Cal)-αhCD163. ( G , H ) Cell culture supernatant was collected from Mφ (n=3). Protein concentration of ( G ) IL-6 *(outlier removed from IL-6 ELISA) and ( H ) TNF-α protein level (pg/mL) was measured using a commercial human IL-6 and TNF-α kit. Dotted horizontal line indicates the protein level detected in control Mφ. Two-way ANOVA with Tukey’s multiple comparisons test was performed. ***Statistically significant difference for all 100 nM LNP types. **For all 10 nM LNP types. @@ For 0.5 nM PEG-LNP(Cal) and 0.5 nM PEG-LNP(Cal)-IgG(h). # 0.5 nM PEG-LNP(Cal) vs 0.5 nM PEG-LNP(Cal)-αhCD163. *0.5 nM PEG-LNP(Cal)-IgG(h) vs 0.5 nM PEG-LNP(Cal)-αhCD163. ( I , J ) MFI of surface markers HLA-DR and CD80 on DID + LPS-induced Mφ pretreated with 10 and 100 nM PEG-LNP(Cal)-αhCD163. Overall MFI of surface markers on live LPS-induced Mφ population; mean MFI HLA-DR: 1978 and mean MFI CD80: 446. Abbreviations: Mφ, macrophages; LNPs, lipid nanoparticles; PEG, polyethylene glycol; PEG-LNP(Cal), calcitriol PEGylated lipid nanoparticles; LPS, lipopolysaccharide; MFI, median fluorescence intensity; TNF-α, tumor necrosis factor-alpha; MCP-1, monocyte chemoattractant protein; NF, nuclear factor; IL, interleukin.
    Cd80 Apc/H7 (Clone L307.4), supplied by Becton Dickinson, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cd80+clone+l307%2E4/anti+cd80/pm32426849-176-50-58
    Average 90 stars, based on 1 article reviews
    cd80-apc/h7 (clone l307.4) - by Bioz Stars, 2026-09
    90/100 stars
      Buy from Supplier

    90
    Becton Dickinson anti-cd80–bb630 (1:50,clone l307.4)
    mRNA gene expression analyses of selected target genes, protein analyses of IL-6 and TNF-α, and analysis of surface marker expression of HLA-DR and <t>CD80</t> to investigate the effects of non-targeted and targeted PEG-LNP(Cal) in LPS-induced human Mφ. ( A – H ) Human Mφ (1×10 6 cells/well) from buffy coats (n=3) were pretreated with different doses (0.5, 10, and 100 nM) of either PEG-LNP(Cal), PEG-LNP(Cal)-IgG(h), or PEG-LNP(Cal)-αhCD163 for 24 hours following LPS challenge (μL/mL) for 4 hours. The second derivative max method was used to calculate the relative mRNA concentration of each sample. Target gene expression levels (NF-κB, TNF-α, MCP-1, IL-6, IL-10, and CD163) were normalized to the stable housekeeping gene GAPDH expression level, and the resulting mRNA ratios were normalized to untreated control Mφ and given the value 1 (dotted horizontal line). Two-way ANOVA along with Tukey’s multiple comparisons test was performed on all targets to investigate the difference between LNP types per dose and the specific dose-dependent response per LNP type. * P ≤0.05, ** P ≤0.01, *** P ≤0.001, and **** P ≤0.0001. Asterisks over the horizontal line indicate dose-dependent significance. ( A ) # 10 nM PEG-LNP(Cal) vs 10 nM PEG-LNP(Cal)-αhCD163, * and **PEG-LNP(Cal)-IgG(h) vs PEG-LNP(Cal)-αhCD163. ( B ) ## PEG-LNP(Cal) vs PEG-LNP(Cal)-αhCD163. ( C ) **The horizontal line above shows dose-dependent significance for non-targeted and targeted PEG-LNP(Cal). ( D ) *The horizontal line above illustrates significant dose-dependent response for PEG-LNP(Cal) and PEG-LNP(Cal)-IgG(h). *For both 0.5 and 10 nM PEG-LNP(Cal)-IgG(h) vs 0.5 and 10 nM PEG-LNP(Cal)-αhCD163. ( E ) # 0.5 nM PEG-LNP(Cal) vs 0.5 nM PEG-LNP(Cal)-αhCD163, *0.5 and 100 nM PEG-LNP(Cal)-IgG(h) vs 0.5 and 100 nM PEG-LNP(Cal)-αhCD163. ( G , H ) Cell culture supernatant was collected from Mφ (n=3). Protein concentration of ( G ) IL-6 *(outlier removed from IL-6 ELISA) and ( H ) TNF-α protein level (pg/mL) was measured using a commercial human IL-6 and TNF-α kit. Dotted horizontal line indicates the protein level detected in control Mφ. Two-way ANOVA with Tukey’s multiple comparisons test was performed. ***Statistically significant difference for all 100 nM LNP types. **For all 10 nM LNP types. @@ For 0.5 nM PEG-LNP(Cal) and 0.5 nM PEG-LNP(Cal)-IgG(h). # 0.5 nM PEG-LNP(Cal) vs 0.5 nM PEG-LNP(Cal)-αhCD163. *0.5 nM PEG-LNP(Cal)-IgG(h) vs 0.5 nM PEG-LNP(Cal)-αhCD163. ( I , J ) MFI of surface markers HLA-DR and CD80 on DID + LPS-induced Mφ pretreated with 10 and 100 nM PEG-LNP(Cal)-αhCD163. Overall MFI of surface markers on live LPS-induced Mφ population; mean MFI HLA-DR: 1978 and mean MFI CD80: 446. Abbreviations: Mφ, macrophages; LNPs, lipid nanoparticles; PEG, polyethylene glycol; PEG-LNP(Cal), calcitriol PEGylated lipid nanoparticles; LPS, lipopolysaccharide; MFI, median fluorescence intensity; TNF-α, tumor necrosis factor-alpha; MCP-1, monocyte chemoattractant protein; NF, nuclear factor; IL, interleukin.
    Anti Cd80–Bb630 (1:50,Clone L307.4), supplied by Becton Dickinson, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cd80+clone+l307%2E4/streptavidin+bv711/pmc08129071-242-41-64
    Average 90 stars, based on 1 article reviews
    anti-cd80–bb630 (1:50,clone l307.4) - by Bioz Stars, 2026-09
    90/100 stars
      Buy from Supplier

    90
    Becton Dickinson cd80 apc-h7-mouse anti-human cd80 (clone l307.4; 561134)
    Schematic illustration of the in vitro effects of the poly(I:C) ENCPs developed in this study. (A) Upon interaction with macrophages, poly(I:C) nanocomplexes are taken up. (B) This process allows poly(I:C) to reach its target receptor TLR3, found in the endosomes. It is expected that this interaction activates the TLR3 and the TRIF pathway, stimulating the upregulation of type I IFN genes. (C) The expression of M2 (CD206 and CD163) surface markers was slightly decreased, while M1 <t>(CD80</t> and MHC II) markers are not substantially modified. Nevertheless, (D) CXCL10 and CCL5 chemokines, involved in the attraction of CD8 T cells to the tumor microenvironment, are secreted. (E) The direct cytotoxicity of macrophages toward cancer cells is also enhanced. Images were reproduced from Servier Medical Art under a Creative Commons Attribution 3.0 Unported License https://creativecommons.org/licenses/by/3.0 .
    Cd80 Apc H7 Mouse Anti Human Cd80 (Clone L307.4; 561134), supplied by Becton Dickinson, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cd80+clone+l307%2E4/anti+cd80/pmc07358452-90-22-35
    Average 90 stars, based on 1 article reviews
    cd80 apc-h7-mouse anti-human cd80 (clone l307.4; 561134) - by Bioz Stars, 2026-09
    90/100 stars
      Buy from Supplier

    90
    Becton Dickinson anti-cd80 (apc-h7, clone l307.4)
    Schematic illustration of the in vitro effects of the poly(I:C) ENCPs developed in this study. (A) Upon interaction with macrophages, poly(I:C) nanocomplexes are taken up. (B) This process allows poly(I:C) to reach its target receptor TLR3, found in the endosomes. It is expected that this interaction activates the TLR3 and the TRIF pathway, stimulating the upregulation of type I IFN genes. (C) The expression of M2 (CD206 and CD163) surface markers was slightly decreased, while M1 <t>(CD80</t> and MHC II) markers are not substantially modified. Nevertheless, (D) CXCL10 and CCL5 chemokines, involved in the attraction of CD8 T cells to the tumor microenvironment, are secreted. (E) The direct cytotoxicity of macrophages toward cancer cells is also enhanced. Images were reproduced from Servier Medical Art under a Creative Commons Attribution 3.0 Unported License https://creativecommons.org/licenses/by/3.0 .
    Anti Cd80 (Apc H7, Clone L307.4), supplied by Becton Dickinson, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cd80+clone+l307%2E4/anti+cd80/pm28439087-205-17-33
    Average 90 stars, based on 1 article reviews
    anti-cd80 (apc-h7, clone l307.4) - by Bioz Stars, 2026-09
    90/100 stars
      Buy from Supplier

    Image Search Results


    mRNA gene expression analyses of selected target genes, protein analyses of IL-6 and TNF-α, and analysis of surface marker expression of HLA-DR and CD80 to investigate the effects of non-targeted and targeted PEG-LNP(Cal) in LPS-induced human Mφ. ( A – H ) Human Mφ (1×10 6 cells/well) from buffy coats (n=3) were pretreated with different doses (0.5, 10, and 100 nM) of either PEG-LNP(Cal), PEG-LNP(Cal)-IgG(h), or PEG-LNP(Cal)-αhCD163 for 24 hours following LPS challenge (μL/mL) for 4 hours. The second derivative max method was used to calculate the relative mRNA concentration of each sample. Target gene expression levels (NF-κB, TNF-α, MCP-1, IL-6, IL-10, and CD163) were normalized to the stable housekeeping gene GAPDH expression level, and the resulting mRNA ratios were normalized to untreated control Mφ and given the value 1 (dotted horizontal line). Two-way ANOVA along with Tukey’s multiple comparisons test was performed on all targets to investigate the difference between LNP types per dose and the specific dose-dependent response per LNP type. * P ≤0.05, ** P ≤0.01, *** P ≤0.001, and **** P ≤0.0001. Asterisks over the horizontal line indicate dose-dependent significance. ( A ) # 10 nM PEG-LNP(Cal) vs 10 nM PEG-LNP(Cal)-αhCD163, * and **PEG-LNP(Cal)-IgG(h) vs PEG-LNP(Cal)-αhCD163. ( B ) ## PEG-LNP(Cal) vs PEG-LNP(Cal)-αhCD163. ( C ) **The horizontal line above shows dose-dependent significance for non-targeted and targeted PEG-LNP(Cal). ( D ) *The horizontal line above illustrates significant dose-dependent response for PEG-LNP(Cal) and PEG-LNP(Cal)-IgG(h). *For both 0.5 and 10 nM PEG-LNP(Cal)-IgG(h) vs 0.5 and 10 nM PEG-LNP(Cal)-αhCD163. ( E ) # 0.5 nM PEG-LNP(Cal) vs 0.5 nM PEG-LNP(Cal)-αhCD163, *0.5 and 100 nM PEG-LNP(Cal)-IgG(h) vs 0.5 and 100 nM PEG-LNP(Cal)-αhCD163. ( G , H ) Cell culture supernatant was collected from Mφ (n=3). Protein concentration of ( G ) IL-6 *(outlier removed from IL-6 ELISA) and ( H ) TNF-α protein level (pg/mL) was measured using a commercial human IL-6 and TNF-α kit. Dotted horizontal line indicates the protein level detected in control Mφ. Two-way ANOVA with Tukey’s multiple comparisons test was performed. ***Statistically significant difference for all 100 nM LNP types. **For all 10 nM LNP types. @@ For 0.5 nM PEG-LNP(Cal) and 0.5 nM PEG-LNP(Cal)-IgG(h). # 0.5 nM PEG-LNP(Cal) vs 0.5 nM PEG-LNP(Cal)-αhCD163. *0.5 nM PEG-LNP(Cal)-IgG(h) vs 0.5 nM PEG-LNP(Cal)-αhCD163. ( I , J ) MFI of surface markers HLA-DR and CD80 on DID + LPS-induced Mφ pretreated with 10 and 100 nM PEG-LNP(Cal)-αhCD163. Overall MFI of surface markers on live LPS-induced Mφ population; mean MFI HLA-DR: 1978 and mean MFI CD80: 446. Abbreviations: Mφ, macrophages; LNPs, lipid nanoparticles; PEG, polyethylene glycol; PEG-LNP(Cal), calcitriol PEGylated lipid nanoparticles; LPS, lipopolysaccharide; MFI, median fluorescence intensity; TNF-α, tumor necrosis factor-alpha; MCP-1, monocyte chemoattractant protein; NF, nuclear factor; IL, interleukin.

    Journal: International Journal of Nanomedicine

    Article Title: Targeted lipid nanoparticle delivery of calcitriol to human monocyte-derived macrophages in vitro and in vivo: investigation of the anti-inflammatory effects of calcitriol

    doi: 10.2147/IJN.S192113

    Figure Lengend Snippet: mRNA gene expression analyses of selected target genes, protein analyses of IL-6 and TNF-α, and analysis of surface marker expression of HLA-DR and CD80 to investigate the effects of non-targeted and targeted PEG-LNP(Cal) in LPS-induced human Mφ. ( A – H ) Human Mφ (1×10 6 cells/well) from buffy coats (n=3) were pretreated with different doses (0.5, 10, and 100 nM) of either PEG-LNP(Cal), PEG-LNP(Cal)-IgG(h), or PEG-LNP(Cal)-αhCD163 for 24 hours following LPS challenge (μL/mL) for 4 hours. The second derivative max method was used to calculate the relative mRNA concentration of each sample. Target gene expression levels (NF-κB, TNF-α, MCP-1, IL-6, IL-10, and CD163) were normalized to the stable housekeeping gene GAPDH expression level, and the resulting mRNA ratios were normalized to untreated control Mφ and given the value 1 (dotted horizontal line). Two-way ANOVA along with Tukey’s multiple comparisons test was performed on all targets to investigate the difference between LNP types per dose and the specific dose-dependent response per LNP type. * P ≤0.05, ** P ≤0.01, *** P ≤0.001, and **** P ≤0.0001. Asterisks over the horizontal line indicate dose-dependent significance. ( A ) # 10 nM PEG-LNP(Cal) vs 10 nM PEG-LNP(Cal)-αhCD163, * and **PEG-LNP(Cal)-IgG(h) vs PEG-LNP(Cal)-αhCD163. ( B ) ## PEG-LNP(Cal) vs PEG-LNP(Cal)-αhCD163. ( C ) **The horizontal line above shows dose-dependent significance for non-targeted and targeted PEG-LNP(Cal). ( D ) *The horizontal line above illustrates significant dose-dependent response for PEG-LNP(Cal) and PEG-LNP(Cal)-IgG(h). *For both 0.5 and 10 nM PEG-LNP(Cal)-IgG(h) vs 0.5 and 10 nM PEG-LNP(Cal)-αhCD163. ( E ) # 0.5 nM PEG-LNP(Cal) vs 0.5 nM PEG-LNP(Cal)-αhCD163, *0.5 and 100 nM PEG-LNP(Cal)-IgG(h) vs 0.5 and 100 nM PEG-LNP(Cal)-αhCD163. ( G , H ) Cell culture supernatant was collected from Mφ (n=3). Protein concentration of ( G ) IL-6 *(outlier removed from IL-6 ELISA) and ( H ) TNF-α protein level (pg/mL) was measured using a commercial human IL-6 and TNF-α kit. Dotted horizontal line indicates the protein level detected in control Mφ. Two-way ANOVA with Tukey’s multiple comparisons test was performed. ***Statistically significant difference for all 100 nM LNP types. **For all 10 nM LNP types. @@ For 0.5 nM PEG-LNP(Cal) and 0.5 nM PEG-LNP(Cal)-IgG(h). # 0.5 nM PEG-LNP(Cal) vs 0.5 nM PEG-LNP(Cal)-αhCD163. *0.5 nM PEG-LNP(Cal)-IgG(h) vs 0.5 nM PEG-LNP(Cal)-αhCD163. ( I , J ) MFI of surface markers HLA-DR and CD80 on DID + LPS-induced Mφ pretreated with 10 and 100 nM PEG-LNP(Cal)-αhCD163. Overall MFI of surface markers on live LPS-induced Mφ population; mean MFI HLA-DR: 1978 and mean MFI CD80: 446. Abbreviations: Mφ, macrophages; LNPs, lipid nanoparticles; PEG, polyethylene glycol; PEG-LNP(Cal), calcitriol PEGylated lipid nanoparticles; LPS, lipopolysaccharide; MFI, median fluorescence intensity; TNF-α, tumor necrosis factor-alpha; MCP-1, monocyte chemoattractant protein; NF, nuclear factor; IL, interleukin.

    Article Snippet: Specific antibodies for flow cytometry and confocal microscopy included the following: human CD80 HRZN V450 (clone: L307.4) was obtained from Becton Dickinson (Franklin Lakes, NJ, USA); FITC antihuman HLA-DR (clone L243) and PE-antihuman CD163 (clone: GHI) were obtained from Nordic BioSite (Taby, Sweden); wheat germ agglutinin Alexa Flour 488 (cat no W11261), Live/Dead (near-infrared stain), and antihuman TNF-α MAB11 EF450 were obtained from Thermo Fisher Scientific.

    Techniques: Expressing, Marker, Concentration Assay, Cell Culture, Protein Concentration, Enzyme-linked Immunosorbent Assay, Fluorescence

    Schematic illustration of the in vitro effects of the poly(I:C) ENCPs developed in this study. (A) Upon interaction with macrophages, poly(I:C) nanocomplexes are taken up. (B) This process allows poly(I:C) to reach its target receptor TLR3, found in the endosomes. It is expected that this interaction activates the TLR3 and the TRIF pathway, stimulating the upregulation of type I IFN genes. (C) The expression of M2 (CD206 and CD163) surface markers was slightly decreased, while M1 (CD80 and MHC II) markers are not substantially modified. Nevertheless, (D) CXCL10 and CCL5 chemokines, involved in the attraction of CD8 T cells to the tumor microenvironment, are secreted. (E) The direct cytotoxicity of macrophages toward cancer cells is also enhanced. Images were reproduced from Servier Medical Art under a Creative Commons Attribution 3.0 Unported License https://creativecommons.org/licenses/by/3.0 .

    Journal: Frontiers in Immunology

    Article Title: Arginine-Based Poly(I:C)-Loaded Nanocomplexes for the Polarization of Macrophages Toward M1-Antitumoral Effectors

    doi: 10.3389/fimmu.2020.01412

    Figure Lengend Snippet: Schematic illustration of the in vitro effects of the poly(I:C) ENCPs developed in this study. (A) Upon interaction with macrophages, poly(I:C) nanocomplexes are taken up. (B) This process allows poly(I:C) to reach its target receptor TLR3, found in the endosomes. It is expected that this interaction activates the TLR3 and the TRIF pathway, stimulating the upregulation of type I IFN genes. (C) The expression of M2 (CD206 and CD163) surface markers was slightly decreased, while M1 (CD80 and MHC II) markers are not substantially modified. Nevertheless, (D) CXCL10 and CCL5 chemokines, involved in the attraction of CD8 T cells to the tumor microenvironment, are secreted. (E) The direct cytotoxicity of macrophages toward cancer cells is also enhanced. Images were reproduced from Servier Medical Art under a Creative Commons Attribution 3.0 Unported License https://creativecommons.org/licenses/by/3.0 .

    Article Snippet: They were then stained with APC-mouse anti-human HLA-DR (552764, BD Biosciences, CA, USA), FITC-mouse anti-human mannose receptor CD206 (551135), anti-human CD163-BV421 (562643), CD80 APC-H7-mouse anti-Human CD80 (Clone L307.4; 561134) and anti-human CD68-PE (556078) (all from BD Biosciences, CA, USA).

    Techniques: In Vitro, Expressing, Modification